Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127379061 | 12737906 | 1 | I | 20160409 | 20160907 | 20160913 | 20160913 | EXP | CH-SM-2016-07051 | CH-ELI_LILLY_AND_COMPANY-CH201609003048 | ELI LILLY AND CO | 40.68 | YR | M | Y | 100.00000 | KG | 20160913 | CN | CH | CH |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127379061 | 12737906 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 10 MG, BID | Y | U | 20592 | 10 | MG | BID | |||||
| 127379061 | 12737906 | 2 | SS | VALPROAT | VALPROATE SODIUM | 1 | Oral | 1000MG-0-1500MG | Y | U | 0 | 2500 | MG | QD | |||||
| 127379061 | 12737906 | 3 | SS | VALPROAT | VALPROATE SODIUM | 1 | Unknown | 1000MG-0-1500MG | Y | U | 0 | 2500 | MG | QD | |||||
| 127379061 | 12737906 | 4 | SS | QUILONORM /00033703/ | LITHIUM ACETATE | 1 | Oral | 8.1 MMOL, TID | Y | U | 0 | 8.1 | MMOL | TID | |||||
| 127379061 | 12737906 | 5 | SS | TRANXILIUM | CLORAZEPATE DIPOTASSIUM | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID | |||||||
| 127379061 | 12737906 | 6 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 5 MG, QD | Y | U | 0 | 5 | MG | QD | |||||
| 127379061 | 12737906 | 7 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, QD | Y | U | 0 | 10 | MG | QD | |||||
| 127379061 | 12737906 | 8 | SS | SOLIAN | AMISULPRIDE | 1 | Oral | 100 MG, QD | Y | U | 0 | 100 | MG | QD | |||||
| 127379061 | 12737906 | 9 | C | PRIADEL /00033702/ | LITHIUM CARBONATE | 1 | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127379061 | 12737906 | 1 | Schizoaffective disorder |
| 127379061 | 12737906 | 2 | Schizoaffective disorder |
| 127379061 | 12737906 | 4 | Schizoaffective disorder |
| 127379061 | 12737906 | 5 | Product used for unknown indication |
| 127379061 | 12737906 | 6 | Schizoaffective disorder |
| 127379061 | 12737906 | 8 | Schizoaffective disorder |
| 127379061 | 12737906 | 9 | Schizoaffective disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127379061 | 12737906 | LT |
| 127379061 | 12737906 | OT |
| 127379061 | 12737906 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127379061 | 12737906 | Acute respiratory distress syndrome | |
| 127379061 | 12737906 | Amylase increased | |
| 127379061 | 12737906 | Encephalopathy | |
| 127379061 | 12737906 | Lipase increased | |
| 127379061 | 12737906 | Neuroleptic malignant syndrome | |
| 127379061 | 12737906 | Neuromyopathy | |
| 127379061 | 12737906 | Pancreatitis | |
| 127379061 | 12737906 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127379061 | 12737906 | 1 | 20160419 | 0 | ||
| 127379061 | 12737906 | 2 | 20160419 | 0 | ||
| 127379061 | 12737906 | 3 | 20160422 | 20160427 | 0 | |
| 127379061 | 12737906 | 4 | 20160420 | 0 | ||
| 127379061 | 12737906 | 7 | 20160427 | 20160430 | 0 | |
| 127379061 | 12737906 | 8 | 20160509 | 0 |